Insider Trading History of Kisner Daniel L

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Kisner Daniel L since 2008. This trader's CIK number is 1073407. At the time of last reporting, Kisner Daniel L was the Director of Zynerba Pharmaceuticals, Inc.. (stock ticker symbol ZYNE). Also see all insider trading activities at Zynerba Pharmaceuticals, Inc..

Note that in the past KISNER DANIEL L also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Oncternal Therapeutics, Inc. (ONCT) by Kisner Daniel L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 ONCT 10,000 $23,830 0 $0 0 $0

Yearly summary of insider trading at Histogen Inc. (CNAT) by Kisner Daniel L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 CNAT 4,000 $23,000 0 $0 0 $0

Yearly summary of insider trading at Caliper Life Sciences Inc (CALP) by Kisner Daniel L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 CALP 0 $0 76,500 $273,548 76,500 $73,970

Yearly summary of insider trading at Dynavax Technologies Corp (DVAX) by Kisner Daniel L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 DVAX 10,000 $10,750 0 $0 0 $0
2012 DVAX 0 $0 0 $0 5,000 $10,100

Yearly summary of insider trading at Zynerba Pharmaceuticals, Inc. (ZYNE) by Kisner Daniel L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 ZYNE 0 $0 115 $40 0 $0
2022 ZYNE 0 $0 40 $40 0 $0


Insider trading activities at 5 companies by Kisner Daniel L:

1. Oncternal Therapeutics, Inc. (ONCT)

2. Histogen Inc. (CNAT)

3. Caliper Life Sciences Inc (CALP)

4. Dynavax Technologies Corp (DVAX)

5. Zynerba Pharmaceuticals, Inc. (ZYNE)

Table 1. Insider trading of Oncternal Therapeutics, Inc. (ONCT) by Kisner Daniel L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-07-21 ONCT Buy 10,000 2.38 23,830

Table 2. Insider trading of Histogen Inc. (CNAT) by Kisner Daniel L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-04-08 CNAT Buy 4,000 5.75 23,000

Table 3. Insider trading of Caliper Life Sciences Inc (CALP) by Kisner Daniel L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-06-03 CALP Option Ex 1,200 .97 1,160
2008-06-03 CALP Sale 1,200 3.50 4,200
2008-06-02 CALP Sale 300 3.51 1,053
2008-05-30 CALP Sale 8,412 3.50 29,442
2008-06-02 CALP Option Ex 300 .97 290
2008-05-30 CALP Option Ex 8,412 .97 8,134
2008-05-16 CALP Sale 3,078 3.50 10,788
2008-05-19 CALP Option Ex 13,510 .97 13,064
2008-05-19 CALP Sale 13,510 3.50 47,352
2008-05-16 CALP Option Ex 3,078 .97 2,976
2008-05-13 CALP Option Ex 617 .97 596
2008-05-13 CALP Sale 617 3.50 2,159
2008-05-06 CALP Option Ex 2,400 .97 2,320
2008-05-06 CALP Sale 2,400 3.54 8,486
2008-05-05 CALP Option Ex 6,583 .97 6,365
2008-05-05 CALP Sale 6,583 3.53 23,211
2008-05-02 CALP Option Ex 9,600 .97 9,283
2008-05-02 CALP Sale 9,600 3.60 34,560
2008-05-01 CALP Sale 5,800 3.62 21,013
2008-05-01 CALP Option Ex 5,800 .97 5,608
2008-04-14 CALP Option Ex 13,700 .97 13,247
2008-04-15 CALP Option Ex 6,000 .97 5,802
2008-04-14 CALP Sale 13,700 3.67 50,210
2008-04-15 CALP Sale 6,000 3.66 21,936
2008-04-16 CALP Option Ex 5,300 .97 5,125
2008-04-16 CALP Sale 5,300 3.61 19,138

Table 4. Insider trading of Dynavax Technologies Corp (DVAX) by Kisner Daniel L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-10-30 DVAX Buy 10,000 1.07 10,750
2012-01-26 DVAX Option Ex 5,000 2.02 10,100

Table 5. Insider trading of Zynerba Pharmaceuticals, Inc. (ZYNE) by Kisner Daniel L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-06-14 ZYNE Sale 115 .35 40
2022-06-14 ZYNE Sale 40 1.01 40

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kisner Daniel L (Director of Zynerba Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.